A detailed history of Lipe & Dalton transactions in Baxter International Inc stock. As of the latest transaction made, Lipe & Dalton holds 12,780 shares of BAX stock, worth $459,952. This represents 0.23% of its overall portfolio holdings.

Number of Shares
12,780
Previous 13,180 3.03%
Holding current value
$459,952
Previous $563,000 24.16%
% of portfolio
0.23%
Previous 0.29%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

SELL
$32.87 - $43.55 $13,147 - $17,420
-400 Reduced 3.03%
12,780 $427,000
Q3 2023

Nov 03, 2023

SELL
$37.32 - $49.29 $13,995 - $18,483
-375 Reduced 2.77%
13,180 $497,000
Q2 2023

Jul 26, 2023

SELL
$39.98 - $47.68 $17,991 - $21,456
-450 Reduced 3.21%
13,555 $618,000
Q1 2023

May 02, 2023

SELL
$37.58 - $52.57 $437,807 - $612,440
-11,650 Reduced 45.41%
14,005 $568,000
Q4 2022

Feb 03, 2023

SELL
$49.7 - $57.71 $223,003 - $258,944
-4,487 Reduced 14.89%
25,655 $1.31 Million
Q3 2022

Nov 07, 2022

SELL
$53.86 - $66.8 $277,702 - $344,420
-5,156 Reduced 14.61%
30,142 $1.62 Million
Q2 2022

Aug 01, 2022

SELL
$63.83 - $80.0 $301,596 - $378,000
-4,725 Reduced 11.81%
35,298 $2.27 Million
Q1 2022

Apr 26, 2022

SELL
$76.85 - $89.45 $37,656 - $43,830
-490 Reduced 1.21%
40,023 $3.1 Million
Q4 2021

Feb 01, 2022

SELL
$74.57 - $87.19 $33,481 - $39,148
-449 Reduced 1.1%
40,513 $3.48 Million
Q3 2021

Nov 01, 2021

SELL
$73.77 - $83.61 $75,614 - $85,700
-1,025 Reduced 2.44%
40,962 $3.3 Million
Q2 2021

Aug 02, 2021

BUY
$80.5 - $88.01 $80 - $88
1 Added 0.0%
41,987 $3.38 Million
Q1 2021

Apr 30, 2021

SELL
$76.38 - $86.03 $42,009 - $47,316
-550 Reduced 1.29%
41,986 $3.54 Million
Q4 2020

Jan 29, 2021

SELL
$75.39 - $82.36 $26,386 - $28,826
-350 Reduced 0.82%
42,536 $3.41 Million
Q3 2020

Oct 30, 2020

SELL
$78.33 - $90.73 $29,295 - $33,933
-374 Reduced 0.86%
42,886 $3.45 Million
Q2 2020

Aug 07, 2020

SELL
$78.66 - $94.14 $29,497 - $35,302
-375 Reduced 0.86%
43,260 $3.73 Million
Q1 2020

May 01, 2020

SELL
$71.57 - $93.3 $96,547 - $125,861
-1,349 Reduced 3.0%
43,635 $3.54 Million
Q4 2019

Jan 21, 2020

SELL
$76.7 - $88.45 $34,515 - $39,802
-450 Reduced 0.99%
44,984 $3.76 Million
Q3 2019

Nov 07, 2019

SELL
$81.4 - $89.78 $303,215 - $334,430
-3,725 Reduced 7.58%
45,434 $3.97 Million
Q2 2019

Jul 24, 2019

SELL
$73.44 - $82.41 $25,630 - $28,761
-349 Reduced 0.7%
49,159 $4.03 Million
Q1 2019

Apr 30, 2019

SELL
$64.48 - $81.31 $80,600 - $101,637
-1,250 Reduced 2.46%
49,508 $4.03 Million
Q4 2018

Feb 08, 2019

SELL
$61.45 - $77.8 $20,401 - $25,829
-332 Reduced 0.65%
50,758 $3.34 Million
Q3 2018

Nov 05, 2018

SELL
$70.71 - $77.75 $44,193 - $48,593
-625 Reduced 1.21%
51,090 $3.94 Million
Q2 2018

Aug 06, 2018

SELL
$63.43 - $75.41 $23,786 - $28,278
-375 Reduced 0.72%
51,715 $3.82 Million
Q1 2018

May 04, 2018

SELL
$62.56 - $72.26 $180,360 - $208,325
-2,883 Reduced 5.24%
52,090 $3.39 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $524,168 - $563,406
-8,530 Reduced 13.43%
54,973 $3.55 Million
Q3 2017

Nov 03, 2017

SELL
$59.5 - $64.61 $985,915 - $1.07 Million
-16,570 Reduced 20.69%
63,503 $3.99 Million
Q2 2017

Aug 08, 2017

BUY
N/A
80,073
80,073 $4.85 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $18.1B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Lipe & Dalton Portfolio

Follow Lipe & Dalton and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lipe & Dalton, based on Form 13F filings with the SEC.

News

Stay updated on Lipe & Dalton with notifications on news.